Cypris Medical, Inc., a company committed to improving outcomes by making plastic surgery less invasive, announced today that an extensive independent audit of its quality management system has successfully culminated in an ISO 13485 certification
“I’m incredibly proud that our pursuit of exceptional product safety and quality resulted in the certification of Cypris Medical’s system for design, development and manufacturing of medical devices,” said Dan Holton, Chief Executive Officer. “ISO certification marks another significant milestone for us as we advance Xact device commercialization. Cypris Medical’s early achievements include ISO-13485 certification, FDA clearance and more than 100 patient procedures using our novel patented technology. It’s clear why we are excited about the journey ahead. We are opening an entirely new door to minimally invasive plastic surgery.”
The initial iteration of Cypris Medical’s technology, the Xact device, is a hand-held surgical suturing tool designed to approximate and pass suture through soft tissue. Facial plastic surgery procedures that incorporate Xact are suitable to be performed without general anesthesia in out-patient settings in less than an hour. Patients typically recover in five days or less. Alternatively, traditional facelift, browlift and necklift surgical treatments require general anesthesia and significantly longer recovery times.
John Speer, VP of Quality Assurance at Greenlight Guru, a quality management software provider for the medical device industry, commended Holton and his team. “Achieving ISO certification is a huge accomplishment for any medical device company. Cypris Medical clearly embraced the importance of dependable quality from day one. As a result, it has been able to rapidly and efficiently design, develop and manufacture the highest quality medical devices possible and breeze through the ISO certification process.”
About Cypris Medical
Headquartered in Chicago, Cypris Medical is committed to improving outcomes by making plastic surgery less invasive. The aesthetics market is growing rapidly, to continue to meet the needs of patients, minimally invasive treatments that provide results comparable to surgery will be needed. Cypris Medical is uniquely qualified to deliver minimally invasive solutions to the market by leveraging more than 100 years of combined experience in medical devices and plastic surgery.
About ISO 13485:2016
ISO is an International Standardization Organization. ISO 13485 is an internationally agreed upon standard that sets out the requirements for a quality management system specific to the medical devices industry.
For more information, visit https://cyprismed.com/ and on Instagram @cyprismedical.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200203005272/en/
Source: Cypris Medical, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20200203005272/en
